| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |